Insiders 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Delayed OTC Markets Other stock markets 08:10:19 15/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	30/23/30	MT
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	30/23/30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	30/23/30	CI
9 Meters Biopharma Names Bethany Sensenig its new Chief Financial Officer	18/22/18	MT
9 Meters Biopharma, Inc. Announces Executive Appointment	03/22/03	CI
9 Meters Biopharma Inc. Appoints Samantha Ventimiglia to Board of Directors	04/21/04	CI
Insider Trends: Selling By Insiders Lingers at 9 Meters Biopharma	26/21/26	MT
9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome	17/21/17	CI
Insider Trends: Insider Buying Added to with Purchase of 9 Meters Biopharma Shares	07/21/07	MT
9 Meters Biopharma Inc Appoints Michael Rice as Board of Director	01/21/01	CI
9 Meters Biopharma, Inc. Announces the Resignation of Nissim Darvish as Director	16/21/16	CI
Insider Trends: 9 Meters Biopharma Insider 90-Day Buying Trend Prolonged with Purchase	18/20/18	MT
9 Meters Biopharma, Inc. Announces the Formation of Its Scientific Advisory Board	31/20/31	CI
9 Meters Biopharma, Inc. Appoints Michael T. Constantino as A Member of the Board and Chair of the Audit Committee	07/20/07	CI
Innovate Biopharma Wt will Change its Name to 9 Meters Biopharma, Inc	11/20/11	CI
9 Meters Biopharma, Inc. Announces Board and Management Changes	05/20/05	CI
Innovate Biopharmaceuticals, Inc. will Change its Name to 9 Meters Biopharma, Inc	04/20/04	CI
Innovate Biopharmaceuticals, Inc. Announces Jay P. Madan, M.S., Will No Longer Serve as the Interim Principal Financial Officer and Interim Principal Accounting Officer	28/19/28	CI
Innovate Biopharmaceuticals, Inc. Announces Executive Changes	20/19/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Insiders

Filters